CFMATTERS is the first randomized, controlled trial comparing the use of microbiome-directed antibiotic treatment versus standard therapy for patients with CF experiencing respiratory infections. The trial is coordinated by Prof. Barry Plant, University College Cork in Ireland and receives funding from the European Union under the 7th framework programme. The video here attached presents the project and the present and upcoming results.